NanoBioMedicine
A special issue of Nanomaterials (ISSN 2079-4991).
Deadline for manuscript submissions: closed (31 July 2020) | Viewed by 49993
Special Issue Editors
Interests: drug delivery; pharmaceutics; pharmacokinetics; drug metabolism
Special Issues, Collections and Topics in MDPI journals
2. Unit of Synthesis and Biomedical Applications of Peptides, IQAC-CSIC, Barcelona, Spain
Interests: drug delivery systems; nanoparticles; biodegradable nanoparticles; neurodegenerative diseases; ocular drug delivery
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Nanomaterials have unique physical and chemical properties attributed to their size between 1 and 100 nm. This nano-size range grants them the capacity to interact with different structures within living organisms and exhibit a set of different biological effects. Nanomaterials have been tested in medicine as drug delivery and targeting approaches for biomolecules. The Special Issue on NanoBioMedicine addresses this multidisciplinary field, aiming at discussing the latest developments on bioengineering strategies to improve therapeutic outcomes, by increasing drug bioavailability, drug targeting capacity, reduce acute/chronic toxicity, reduce drug resistance, etc. Colleagues are invited to participate in this Special Issue, by proposing original and review papers that deal with nanomedicines applied in biomedical sciences, with a special focus on targeting capacity of surface-tailored nanoparticles and their toxicological assessment.
Prof. Dr. Eliana B. Souto
Prof. Dr. Elena Sanchez-Lopez
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Nanomaterials is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- nanocarriers
- nanoparticles
- drug delivery
- nanomedicine
- nanobiotechnology
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.